The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Interleukin-1 receptor antagonist competitively inhibits the binding of interleukin-1 to the type II interleukin-1 receptor
Open accessAbstract
The interleukin-1 receptor antagonist (IL-1ra) inhibits the binding of interleukin-1 (IL-1) to T-cell lines possessing the type I IL-1 receptor; evidence has been published (Carter, D. B., Deibel, M. R. J., Dunn, C. J., Tomich, C. S., Laborde, A. L., Slightom, J. L., Berger, A. E., Bienkowski, M. J., Sun, F. F., McEwan, R. N., Harris, P. K. W., Yem, A. W., Waszak, G. A., Chosay, J. G., Sieu, L. C., Hardee, M. M., Zurcher-Neely, H. A., Reardon, I. M., Heinrickson, R. L., Truesdell, S. E., Shelly, J. A., Eessalu, T. E., Taylor, B. M., and Tracey, D. E. (1990) Nature 344, 633-638; Hannum, C. H., Wilcox, C. J., Arend, W. P., Joslin, F. G., Dripps, D. J., Heimdal, P. L., Armes, L. G., Sommer, A., Eisenberg, S. P., and Thompson, R. C. (1990) Nature 343, 336-340) that IL-Ira does not bind to the type II IL-1 receptor (IL-1RtII). In this study we examined the ability of human recombinant IL-1ra to block the binding of IL-1 to the IL-1RtII on human polymorphonuclear leukocytes (PMN) and Raji human B-lymphoma cells. The binding of 125I-IL-1 beta to PMN was competively inhibited by IL-1ra. IL-1 beta was more potent in inhibiting the binding of 125I-IL-1 beta than IL-1ra. Incubating PMN with 125I-IL-1ra in the presence of increasing concentrations of IL-1 beta or IL-1ra showed that IL-1 beta was an approximately 40-fold more potent inhibitor of binding of 125I-IL-1ra than unlabeled IL-1ra. The IL-1ra was approximately 500-fold less potent in inhibiting the binding of 125I-IL-1 alpha than IL-1 alpha. IL-1ra was also able to competitively inhibit binding of 125I-IL-1 beta to Raji cells. PMN or Raji cells were also incubated with 125I-IL-1 in the absence or presence of IL-1 or IL-1ra. After cross-linking of IL-1 to cells followed by specific immunoprecipitation, sodium dodecyl sulfate-polyacrylamide gel electrophoresis showed a band at 85 kDa corresponding to the 68-kDa IL-1RtII. However, in the presence of an excess of either unlabeled IL-1 or IL-1ra, the 85-kDa IL-1.IL-1RtII complex was not present. These findings demonstrate that the IL-1ra recognizes and blocks IL-1 binding to the IL-1RtII.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yung-Chi, C., & Prusoff, W. H. (1973) · Biochemical Pharmacology · doi:10.1016/0006-2952(73)90196-2 · Cited by 12,922
Interleukin-1 and interleukin-1 antagonism
Dinarello, C. (1991) · Blood · doi:10.1182/blood.v77.8.1627.1627 · Cited by 2,304
Self-citationInterleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor
Hannum, C. H., Wilcox, C. J., Arend, W. P., Joslin, F. G., Dripps, D. J., Heimdal, P. L., Armes, L. G., Sommer, A., Eisenberg, S. P., & Thompson, R. C. (1990) · Nature · doi:10.1038/343336a0 · Cited by 1,122
Eisenberg, S. P., Evans, R. J., Arend, W. P., Verderber, E., Brewer, M. T., Hannum, C. H., & Thompson, R. C. (1990) · Nature · doi:10.1038/343341a0 · Cited by 1,088
Carter, D. B., Deibel, M. R., Dunn, C. J., Tomich, C.-S. C., Laborde, A. L., Slightom, J. L., Berger, A. E., Bienkowski, M. J., Sun, F. F., McEwan, R. N., et al. (1990) · Nature · doi:10.1038/344633a0 · Cited by 601
CORRELATION OF PLASMA INTERLEUKIN 1 LEVELS WITH DISEASE ACTIVITY IN RHEUMATOID ARTHRITIS
Eastgate, J., Wood, N., Di Giovine, F., Symons, J., Grinlinton, F., & Duff, G. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90185-7 · Cited by 484
A urine inhibitor of interleukin 1 activity that blocks ligand binding.
Seckinger, P., Lowenthal, J. W., Williamson, K., Dayer, J. M., & MacDonald, H. R. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.5.1546 · Cited by 345
Interleukin 1 alpha and interleukin 1 beta bind to the same receptor on T cells.
Kilian, P. L., Kaffka, K. L., Stern, A. S., Woehle, D., Benjamin, W. R., Dechiara, T. M., Gubler, U., Farrar, J. J., Mizel, S. B., & Lomedico, P. T. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.12.4509 · Cited by 285
Ferrante, A., Nandoskar, M., Walz, A., Goh, D. H. B., & Kowanko, I. C. (1988) · International Archives of Allergy and Immunology · doi:10.1159/000234610 · Cited by 174
The effects of interleukin 1 on human B cell activation and proliferation.
Falkoff, R., Muraguchi, A., Hong, J., Butler, J. L., Dinarello, C. A., & Fauci, A. S. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.131.2.801 · Cited by 151
Self-citationInterleukin 1 as an autocrine growth factor for acute myeloid leukemia cells.
Cozzolino, F., Rubartelli, A., Aldinucci, D., Sitia, R., Torcia, M. G., SHAW, A. R., & Guglielmo, R. D. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.7.2369 · Cited by 147
Dower, S., Call, S. M., Gillis, S. A., & Urdal, D. L. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.4.1060 · Cited by 144
Kupper, T. S., Lee, F., Birchall, N. M., et al. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113792 · Cited by 135
Interleukin-1 accelerates autocrine growth of myeloma cells through interleukin-6 in human myeloma
Kawano, M., Tanaka, H., Ishikawa, H., Nobuyoshi, M., Iwato, K., Asaoku, H., Tanabe, O., & Kuramoto, A. (1989) · Blood · doi:10.1182/blood.v73.8.2145.2145 · Cited by 131
Horuk, R., Huang, J., Covington, M., & Rc, N. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)49250-2 · Cited by 123
Delwel, R., van Buitenen, C., Salem, M. A., Bot, F., Gillis, S., Kaushansky, K., Altrock, B., & Löwenberg, B. (1989) · Blood · doi:10.1182/blood.v74.2.586.586 · Cited by 88
Bagby, G. C., Dinarello, C. A., Neerhout, R. C., Ridgway, D., & McCall, E. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113748 · Cited by 71
Self-citationBendtzen, K., Buschard, K., Diamant, M., Horn, T. L., & Svenson, M. (1989) · PubMed · Cited by 56
Sullivan, G. W., Carper, H. T., Sullivan, J. A., Murata, T., & Mandell, G. L. (1989) · Journal of Leukocyte Biology · doi:10.1002/jlb.45.5.389 · Cited by 52
Rambaldi, A., Terao, M., Bettoni, S., Tini, M., Bassan, R., Barbui, T., & Garattini, E. (1990) · Blood · doi:10.1182/blood.v76.12.2565.2565 · Cited by 50
Characterization of the human interleukin 1 receptor on human polymorphonuclear leukocytes
Rhyne, J. A., Mizel, S. B., Taylor, R., et al. (1988) · Clinical Immunology and Immunopathology · doi:10.1016/0090-1229(88)90029-3 · Cited by 44
Borish, L., Rosenbaum, R., McDonald, B., et al. (1990) · Inflammation · doi:10.1007/bf00917454 · Cited by 26
Interleukin-2 production is suppressed by dietary N-3 fatty acids but enhanced by oral aspirin
Endres, S., Meydani, S. N., Ghorbani, R., Schindler, R., Dempsey, R. A., & Dinarello, C. A. (1989) · Cytokine · doi:10.1016/1043-4666(89)91157-5 · Cited by 7
Self-citation
Cited by
Interleukin-1 Type II Receptor: A Decoy Target for IL-1 That Is Regulated by IL-4
Colotta, F., Re, F., Muzio, M., Bertini, R., Polentarutti, N., Sironi, M., Giri, J. G., Dower, S. K., Sims, J. E., & Mantovani, A. (1993) · Science · doi:10.1126/science.8332913 · Cited by 980
Opal, S. M., Fisher, C. J., Dhainaut, J.-F. A., Vincent, J.-L., Brase, R., Lowry, S. F., Sadoff, J. C., Slotman, G. J., Levy, H., Balk, R. A., et al. (1997) · Critical Care Medicine · doi:10.1097/00003246-199707000-00010 · Cited by 865
Shakoory, B., Carcillo, J. A., Chatham, W. W., Amdur, R. L., Zhao, H., Dinarello, C. A., Cron, R. Q., & Opal, S. M. (2016) · Critical Care Medicine · doi:10.1097/ccm.0000000000001402 · Cited by 867
Self-citationBlocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro
Dinarello, C. A., & Thompson, R. C. (1991) · Immunology Today · doi:10.1016/0167-5699(91)90142-g · Cited by 724
Self-citationInterleukin-1 Receptor Antagonist
Arend, W. P. (1993) · Advances in Immunology · doi:10.1016/s0065-2776(08)60535-0 · Cited by 671
Metadata
- Authors
- Granowitz, E. V., Clark, B. D., Mancilla, J., & Dinarello, C. A.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1991-08
- Volume
- 266
- Issue
- 22
- Pages
- 14147-14150
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1566331874
- Cited by
- 267
- References
- 23
- FWCI
- 10.32
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.